Potent neutralization of SARS-CoV-2 variants of concern by an antibody with a unique genetic signature and structural mode of spike recognition
Kevin J. Kramer(Vanderbilt University Medical Center), Ivelin S. Georgiev(Vanderbilt University), Andrea R. Shiakolas(Vanderbilt University Medical Center), Jazmean K. Williams(Integral Molecular (United States)), Clinton Holt(Vanderbilt University Medical Center), Robert H. Carnahan(Vanderbilt University Medical Center), Alexander Bukreyev(Galveston College), Rachel E. Sutton(Vanderbilt University Medical Center), Nagarajan Raju(Vanderbilt University Medical Center), Daniel Wrapp(Duke University), James E. Crowe(Vanderbilt University Medical Center), Naveenchandra Suryadevara(Vanderbilt University), Edgar Davidson(Integral Molecular (United States)), Nicole V. Johnson(The University of Texas at Austin), Benjamin J. Doranz(Integral Molecular (United States)), Seth J. Zost(Vanderbilt University Medical Center), Ariana Paulo(Vanderbilt University Medical Center), Sivakumar Periasamy(Albany Medical Center Hospital), Ching‐Lin Hsieh(The University of Texas at Austin), Jason S. McLellan(The University of Texas at Austin)
Cited by 1
Related Papers
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
|Science|2020|9.8k
Site-specific glycan analysis of the SARS-CoV-2 spike
|Science|2020|1.7k
Structure-based design of prefusion-stabilized SARS-CoV-2 spikes
|Science|2020|1.4k
Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen
|Proceedings of the National Academy of Sciences|2017|1.2k